Stay updated on Atezo & Tiragolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.

Latest updates to the Atezo & Tiragolumab in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpdate includes a funding/status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference11%
- Check23 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%
- Check37 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.7%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new study status dates and recruitment statuses. Notably, previous location details and certain status updates have been removed.SummaryDifference21%
- Check65 days agoChange DetectedThe page has been updated to reflect that results have been submitted, and the revision number has changed from v2.16.11 to v2.16.12.SummaryDifference0.8%
Stay in the know with updates to Atezo & Tiragolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.